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ABSTRACT
For the past 20 years, the GPCRDB (G protein-
coupled receptors database; http://www.gpcr.org/
7tm/) has been a ‘one-stop shop’ for G protein-
coupled receptor (GPCR)-related data. The
GPCRDB contains experimental data on sequences,
ligand-binding constants, mutations and oligomers,
as well as many different types of computationally
derived data, such as multiple sequence alignments
and homology models. The GPCRDB also provides
visualization and analysis tools, plus a number of
query systems. In the latest GPCRDB release,
all multiple sequence alignments, and >65 000
homology models, have been significantly
improved, thanks to a recent flurry of GPCR X-ray
structure data. Tools were introduced to browse
X-ray structures, compare binding sites, profile
similar receptors and generate amino acid conser-
vation statistics. Snake plots and helix box diagrams
can now be custom coloured (e.g. by chemical
properties or mutation data) and saved as figures.
A series of sequence alignment visualization tools
has been added, and sequence alignments can
now be created for subsets of sequences and
sequence positions, and alignment statistics can
be produced for any of these subsets.
INTRODUCTION
G protein-coupled receptors (GPCRs) constitute a large
family of cell surface receptors. They regulate a wide
range of cellular processes, including those associated
with taste, smell and vision, and they control myriad intra-
cellular systems, ranging from neurotransmission to
hormone signalling. GPCRs are major targets for the
pharmaceutical industry, as reﬂected by the fact that
more than a quarter of all FDA-approved drugs act on
a GPCR (1). At present, only 30 of the 350 genes that
code for non-olfactory receptors in the human species (2)
are truly validated therapeutic targets (3), indicating this
family’s immense potential for future drug development.
An increasing number of drugs have been found to display
polypharmacology, i.e. activity through multiple receptor
targets (4). However, endogenous ligands for 135 of the
so-called orphan receptors have so far eluded researchers.
Early releases of the GPCRDB (5–8) focused on the
compilation and homogeneous presentation of many
types of heterogeneous data, with the aim of providing
the four main facilities needed in an information system:
browsing, querying, retrieval and inference. The ﬁrst three
of these facilities have been available ever since the start of
the project, but received a major boost when the
GPCRDB was coupled to an intelligent PDF reader (9)
that puts all relevant aspects of the GPCRDB non-intru-
sively in a side-bar in the PDF reader window. Inference
really only started when a number of interactive tools were
added (10), enabling bioinformaticians to interact with
multiple sequence alignments, together with derived data
such as entropy and variability scores, in an integrated
environment. For example, these tools were successfully
applied in the 2010 GPCR-Dock competition (11). In the
past, computing facilities were aimed at expert GPCR
bioinformaticians. In contrast, the new interactive tools
are readily accessible to non-expert users and allow
faster execution of visualization and analysis tasks.
STRUCTURAL DATA AND TOOLS
Crystal structure browser
In recent years, X-ray crystallography of GPCRs has
revealed the sites and mechanisms for binding ligands,
lipids, and G proteins, as well as the conformations of
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activated states. The GPCRDB structure browser includes
manually annotated key data for all ligand–receptor
complexes and at least one (the highest resolution) repre-
sentative ﬁle for receptors solved only as apo structures.
The structure browser can select crystal structures based
on a series of ﬁlters for receptors, ligands, activation
states, G protein presence, PDB and Pubmed identiﬁers,
resolution, structure completeness and so forth. Sequence
similarities can be retrieved by specifying a receptor refer-
ence, facilitating template selection for homology
modelling.
Structure-based sequence alignments and homology models
GPCR transmembrane (TM) helices are known to contain
many irregularities. However, it was only recently realized,
with the availability of new crystallographic data, that
GPCRs contain many more -bulges than those in helix
II and helix V. The -bulges in GPCRs are relatively non-
conserved. As an example of this non-conservation,
Figure 1 shows the -bulges in helix V of rhodopsin and
the adenosine 2A receptor, and Figure 2 shows the align-
ment of the middle part of helix II in 60 trace amine re-
ceptors. The receptors are on average 70% sequence
identical, but the bulge is only present in around half of
all family members.
The abundance of -bulges required a novel residue
numbering approach that involved rewriting the DSSP
secondary structure analysis software (15) and the
GPCR-speciﬁc alignment software. This, in turn, meant
that >65 000 homology models had to be constructed
again. All GPCR sequences are now modelled twice-
once using as template the most sequence-similar
inactive form, and once using the most similar active
form. Modelling was done with YASARA (16), aligning
the model with the template contained in the GPCRDB
and using default values for all other parameters and
options. All GPCR alignment proﬁles were manually
updated to reﬂect our latest knowledge about the -
bulges, and all 1272 alignments were regenerated. It
seems likely that this exercise will need to be repeated in
the coming years as new GPCR structure data reveal new
-bulge patterns.
Translation of generic and receptor-speciﬁc residue
numbers
We wanted to take proper care of the -bulges that are
widely present in six of the seven GPCR TM helices
without excessively changing the commonly used generic
residue numbering schemes. The Oliveira numbering (17)
and the B&W numbers (18) were maintained as far as
possible, whereas bulge residues were given the same
number as the residue directly N-terminal in the
sequence but with a digit added that reﬂects the number
of the bulge. The Utopia-GPCRDB PDF reader automat-
ically takes these new numbers into account, whereas our
new sequence indexing tool provides computational access
to all generic and receptor-speciﬁc residue numbers for
selected receptors.
RECEPTOR SEQUENCE DIAGRAMS
Snake-like and helix box diagrams
Snake-like diagrams now include the full loops and
terminal sequences (Figure 3A). New helix box diagrams
present the TM helices as seen from ‘above’ (Figure 3A).
These diagrams are similar to previously used helical
wheel plots but orient the amino acids in better agreement
with the 3D structures. Hovering the computer mouse
pointer over the TM amino acids displays their residue
numbers. Amino acids can be coloured to illustrate their
physicochemical properties, or the presence of mutation
data or the mutation effects. The diagrams can be down-
loaded as picture ﬁles or in scalable vector graphics format
to allow further editing.
Residue conservation and property statistics
In functional or evolutionary studies of speciﬁc amino
acids or their properties, it is typically relevant to ﬁnd
Figure 1. The area around the bulge in helix V. The S1P lipid receptor
[red, PDBid=3v2y (12)] does not have a-bulges in helix V and is
provided as a reference. Rhodopsin [green, PDBid=1f88 (13)] and the
adenosine-2A receptor [purple, PDBid=3eml (14)] have an a-bulge (red
arrow) between positions 5165.46 and 5175.47. The adenosine-2A receptor
has an extra bulge (blue arrow) between positions 5115.41 and 5125.42.
Rhodopsin and the adenosine-2A receptor have a proline at position
5205.50. The S1P lipid receptor, which does not have bulges in helix V,
does not have a proline at position 5205.50. Time will tell whether this
correlation is accidental or causal. Residues are numbered using the
GPCRDB scheme with the B&W numbers given as superscripts.
Figure 2. Alignment of the middle part of TM helix II in 60 trace
amine receptors. The residues 2272.57–2332.63 (GPCRDB numbers
with B&W numbers as superscripts) are shown running vertically
using the GPCRDB numbering scheme.
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out which additional receptors share the conserved amino
acids or properties (e.g. speciﬁc charge or hydrophobi-
city). Therefore, sequence alignments are augmented
with a series of statistics. For each position, the following
data are listed: the consensus sequence, the percentage of
each of the 20 amino acids present, and percentages for
relevant properties such as aromaticity, acidity or
hydrogen bonding capability.
(BINDING) SITE-SPECIFIC RECEPTOR
SIMILARITIES
Alignment sub-site/domain selections
The alignment and similarity tools integrated into
GPCRDB offer users the ability to select arbitrary com-
binations of helices, residue positions or predeﬁned sets of
residues, for example, the amino acids in the TM binding
cavity (19). By focusing on a given functional site rather
than the full sequence, the receptor similarities will better
reﬂect the structural features involved in, for example,
receptor dimerization, ligand binding or G protein
binding.
Similarity search with a reference receptor (one-to-all
similarities)
Similarity searches are conducted by specifying a target of
interest, a set of receptors and the residue positions of
interest. Results are presented as a sequence alignment,
in which the target is followed by a list of hits in order
of sequence identity, similarity or alignment score. The
data can be downloaded as either an alignment ﬁle or a
spreadsheet.
Trees (all-to-all similarities)
Neighbour-joining trees (20) can be generated based on
any sub-site/domain and set of receptors. Trees can be
calculated with up to 100 bootstraps, displayed in
circular and ladder representations, and downloaded in
Newick format for use with stand-alone tree software.
Sequence motif search (conserved and non-conserved
separation)
The sequence motif search tool generates more precise and
discriminative results, by allowing residues to be matched
for relevant amino acid properties (21), e.g. their hydro-
phobicity, hydrogen bond donor capability or size.
Relevant applications for this tool include rationalization
of observed polypharmacology, receptor panel selection
for off target screening and ligand inference from old to
new targets.
CONCLUSIONS
The 20th yearly release of the GPCRDB includes a large
number of novel discoveries. The solved structures (see
http://gpcr.scripps.edu/) reveal the presence of many -
bulges that are not conserved among or even within
GPCR subfamilies. We have updated all the alignments
and homology models, together with the residue number-
ing schemes, to ensure agreement between the contents of
the GPCRDB and new insights obtained by studying all
the available structure data. Additionally, the new
GPCRDB release includes a powerful yet user-friendly
computational toolbox that provides users with crystal
structure browser, receptor visualization and alignment
analysis tools, plus options to study receptor similarity
both quantitatively and graphically.
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Figure 3. Snake-like (A) and helix box (B) diagrams depict GPCRs from the side and top, respectively.
D424 Nucleic Acids Research, 2014, Vol. 42, Database issue
 at D
anm
arks N
aturO
G
 on June 8, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
FUNDING
Lundbeck Foundation [R54-A5441 to V.I.]; the Carlsberg
Foundation [R77-A6854 to D.G.] and the European
Union NewProt project [289350 to G.V.]. Funding for
open access charge: The publication will be paid by the
CMBI running costs.
Conﬂict of interest statement. None declared.
REFERENCES
1. Overington,J.P., Al-Lazikani,B. and Hopkins,A.L. (2006) How
many drug targets are there? Nat. Rev. Drug Discov., 5, 993–996.
2. Davenport,A.P., Alexander,S.P., Sharman,J.L., Pawson,A.J.,
Benson,H.E., Monaghan,A.E., Liew,W.C., Mpamhanga,C.P.,
Bonner,T.I., Neubig,R.R. et al. (2013) International Union of
Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled
receptor list: recommendations for new pairings with cognate
ligands. Pharmacol. Rev., 65, 967–986.
3. Klabunde,T. and Hessler,G. (2002) Drug design strategies for
targeting G-protein-coupled receptors. Chembiochem, 3, 928–944.
4. Reddy,A.S. and Zhang,S. (2013) Polypharmacology: drug
discovery for the future. Exp. Rev. Clin. Pharmacol., 6, 41–47.
5. Vroling,B., Sanders,M., Baakman,C., Borrmann,A., Verhoeven,S.,
Klomp,J., Oliveira,L., de Vlieg,J. and Vriend,G. (2011) GPCRDB:
information system for G protein-coupled receptors. Nucleic Acids
Res., 39, 309–319.
6. Horn,F., Bettler,E., Oliveira,L., Campagne,F., Cohen,F.E. and
Vriend,G. (2003) GPCRDB information system for G protein-
coupled receptors. Nucleic Acids Res., 31, 294–297.
7. Horn,F., Vriend,G. and Cohen,F.E. (2001) Collecting and
harvesting biological data: the GPCRDB and NucleaRDB
information systems. Nucleic Acids Res., 29, 346–349.
8. Horn,F., Weare,J., Beukers,M.W., Horsch,S., Bairoch,A.,
Chen,W., Edvardsen,O., Campagne,F. and Vriend,G. (1998)
GPCRDB: an information system for G protein-coupled
receptors. Nucleic Acids Res., 26, 275–279.
9. Vroling,B., Thorne,D., McDermott,P., Attwood,T.K., Vriend,G.
and Pettifer,S. (2011) Integrating GPCR-speciﬁc information with
full text articles. BMC Bioinformatics, 12, 362.
10. Sanders,M.P., Verhoeven,S., de Graaf,C., Roumen,L., Vroling,B.,
Nabuurs,S.B., de Vlieg,J. and Klomp,J.P. (2011) Snooker: a
structure-based pharmacophore generation tool applied to class
A GPCRs. J. Chem. Inf. Model., 51, 2277–2292.
11. Kufareva,I., Rueda,M., Katritch,V., Stevens,R.C. and Abagyan,R.
(2011) Status of GPCR modeling and docking as reﬂected by
community-wide GPCR Dock 2010 assessment. Structure, 19,
1108–1126.
12. Hanson,M.A., Roth,C.B., Jo,E., Grifﬁth,M.T., Scott,F.L.,
Reinhart,G., Desale,H., Clemons,B., Cahalan,S.M., Schuerer,S.C.
et al. (2012) Crystal structure of a lipid G protein-coupled
receptor. Science, 335, 851–855.
13. Palczewski,K., Kumasaka,T., Hori,T., Behnke,C.A.,
Motoshima,H., Fox,B.A., Le,T.I., Teller,D.C., Okada,T.,
Stenkamp,R.E. et al. (2000) Crystal structure of rhodopsin:
a G protein-coupled receptor. Science, 289, 739–745.
14. Jaakola,V.-P., Grifﬁth,M.T., Hanson,M.A., Cherezov,V.,
Chien,E.Y.T., Lane,J.R., Ijzerman,A.P. and Stevens,R.C. (2008)
The 2.6 angstrom crystal structure of a human A2A adenosine
receptor bound to an antagonist. Science, 322, 1211–1217.
15. Joosten,R.P., te Beek,T.A., Krieger,E., Hekkelman,M.L.,
Hooft,R.W., Schneider,R., Sander,C. and Vriend,G. (2011)
A series of PDB related databases for everyday needs. Nucleic
Acids Res., 39, D411–D419.
16. Krieger,E., Nabuurs,S.B. and Vriend,G. (2003) Homology
modeling. Methods Biochem. Anal., 44, 509–523.
17. Oliveira,L., Paiva,A.C.M. and Vriend,G. (1993) A common motif
in G-protein-coupled seven transmembrane helix receptors.
J. Comput. Aided Mol. Des., 7, 649–658.
18. Ballesteros,J.A. and Weinstein,H. (1995) Integrated methods for
the construction of three-dimensional models and computational
probing of structure-function relations in G protein-coupled
receptors. Methods Neurosci., 25, 366–428.
19. Gloriam,D.E., Foord,S.M., Blaney,F.E. and Garland,S.L. (2009)
Deﬁnition of the G protein-coupled receptor transmembrane
bundle binding pocket and calculation of receptor similarities
for drug design. J. Med. Chem., 52, 4429–4442.
20. Felsenstein,J. (1989) PHYLIP - Phylogeny Inference Package
(Version 3.2). Cladistics, 5, 164–166.
21. Garland,S. and Gloriam,D. (2011) Methods for the successful
application of chemogenomics to GPCR drug design. Curr. Top.
Med. Chem., 11, 1870–1871.
Nucleic Acids Research, 2014, Vol. 42, Database issue D425
 at D
anm
arks N
aturO
G
 on June 8, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
